<?xml version="1.0" encoding="UTF-8"?>
<ref id="B146-biomedicines-08-00060">
 <label>146.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Forsyth</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rold√°n</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>George</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Wallace</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Morris</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Cairncross</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Matthews</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Markert</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gillespie</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas</article-title>
  <source>Mol. Ther.</source>
  <year>2008</year>
  <volume>16</volume>
  <fpage>627</fpage>
  <lpage>632</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.mt.6300403</pub-id>
  <pub-id pub-id-type="pmid">18253152</pub-id>
 </element-citation>
</ref>
